Syneos Health’s David Thompson in a recent Value & Outcomes Spotlight article spotlights how drugmakers are dealing with increased emphasis on virtual research.
The COVID-19 pandemic, he writes, has ultimately ramped up the incorporation of more digital approaches in the clinical research landscape.
“The digital revolution in health is invading the clinical research realm, and nowhere is this invasion more pronounced than the real-world setting,” he writes. “The COVID-19 pandemic has acted to accelerate these developments on all fronts.”
To read the article in PDF format, click here.